Development of a Shared Decision Tool to Help Women Use the Levonorgestrel-releasing Intrauterine System for Preventing Endometrial Cancer

What this Trial Is About

Researchers are developing an educational tool to help women at risk of endometrial cancer (EC) and healthcare professionals make informed decisions about prevention options, including the use of a levonorgestrel-releasing intrauterine system (LNG-IUS). The study aims to create a personalized decision support tool to prepare patients for discussions with clinicians about LNG-IUS as a primary prevention strategy. This observational study is led by M.D. Anderson Cancer Center and focuses on understanding patient needs and values. The study is conducted in two phases. Phase 1 involves identifying decisional needs, patient values, and experiences regarding LNG-IUS through surveys and questionnaires. Phase 2 focuses on developing and pilot testing a web-based shared decision-making (SDM) tool available in English and Spanish, which includes a personalized EC risk calculator. This tool is intended to support women in making prevention decisions but does not replace clinical consultations. Participants will complete surveys and questionnaires assessing their preferences and values related to LNG-IUS use. The researchers will measure outcomes using a Patient Utility Questionnaire over approximately one year. The study includes both women affected and unaffected by EC, as well as healthcare providers. The total participation time varies by participant, and the study monitors how well the tool supports decision-making about EC prevention.

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer